# Maxymune Therapeutics, Inc. — Form D

Maxymune Therapeutics, Inc. of LOS ALTOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-28. The offering totals $2.5M, of which $850K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-02-28
- Form: D
- Accession: 0002058052-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $850K
- Remaining: $1.6M
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2025-02-11
- Revenue range: No Revenues
- SEC file number: 021-539494

## Issuer

- Name: Maxymune Therapeutics, Inc.
- CIK: 0002058052
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 95 MAIN ST. SUITE 9, LOS ALTOS, CA, 94022
- Phone: 650-892-1942

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Gordon Ringold | Director | Truckee, CA |
| Neil Solomons | Director | Victoria, A1 |
| Tatjana Naranda | Executive Officer | Los Altos, CA |
| Gordon Ringold | Executive Officer | Truckee, CA |
| Tatjana Naranda | Related Person | Los Altos, CA |
| Neil Solomons | Related Person | Victoria, A1 |
| Gordon Ringold | Related Person | Truckee, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-06-03](https://search.stillhousedata.com/formd/0002058052-26-000004) | D/A | $4.5M | $2.7M |

## More

- [CIK 2058052 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2058052&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002058052-25-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.